Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/toxres/tfab015 http://scihub22266oqcxt.onion/10.1093/toxres/tfab015 34183901!8108626!34183901     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Toxicol+Res+(Camb) 2021 ; 10 (2): 299-311 Nephropedia Template TP {{tp|p=34183901|t=2021. COVID-19, hydroxychloroquine and the importance of disease progression |pdf=|usr=}}{{34183901}} gab.com Text COVID-19, hydroxychloroquine and the importance of disease progression JO: Toxicol Res (Camb) http://www.kidney.de/pget.php?&tw=1&pmid=34183901 #FOAvip The COVID-19 pandemic struck swiftly and forcefully. The medical response both commercial and clinical achieved what it could with the resources it had. In addition, society changed old habits and developed new behavior patterns. It is appropriate to identify what lessons were learned from COVID-19 for the future. The most important observation for managing SARS-CoV-2 infections was the identification, but not necessarily appreciation, of the manner in which the virus acts over time in the host that it infects. Based on population densities, the ease with which people are mobile and the way that SARS-CoV-2 infected humans, other infectious diseases can easily become pandemics in the future. This review is not focused on a xenobiotic and its toxicant properties. Rather, the review describes the relationship between a therapeutic (hydroxychloroquine) and the progression of a disease (SARS-CoV-2) along with the timing and sequence of the various pathologies that the disease causes. While at first glance, this may appear to beyond the scope of toxicology, it is not. Toxicology is capable to address disease-induced pathologies because it can use the same skills and tools that it uses for pathologies that xenobiotics cause. Assessing the pathology caused by a disease concurrently with the pathology caused by the drug used to treat the disease, puts toxicology in a position to make a greater contribution to drug development. Repurposing toxicology, just as drugs were repurposed for the COVID-19 pandemic, will avoid missing or misusing a useful therapeutic agent just because the disease-initiated pathology was ignored or unappreciated. Twit Text FOAVip COVID-19, hydroxychloroquine and the importance of disease progression ????Toxicol Res (Camb) http://www.kidney.de/pget.php?&tw=1&pmid=34183901 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34183901 #FOAvip English Wikipedia <ref>{{Cite pmid|34183901}}</ref> COVID-19, hydroxychloroquine and the importance of disease progression #MMPMID34183901 Budny JA Toxicol Res (Camb) 2021[Mar]; 10 (2): 299-311 PMID34183901show ga The COVID-19 pandemic struck swiftly and forcefully. The medical response both commercial and clinical achieved what it could with the resources it had. In addition, society changed old habits and developed new behavior patterns. It is appropriate to identify what lessons were learned from COVID-19 for the future. The most important observation for managing SARS-CoV-2 infections was the identification, but not necessarily appreciation, of the manner in which the virus acts over time in the host that it infects. Based on population densities, the ease with which people are mobile and the way that SARS-CoV-2 infected humans, other infectious diseases can easily become pandemics in the future. This review is not focused on a xenobiotic and its toxicant properties. Rather, the review describes the relationship between a therapeutic (hydroxychloroquine) and the progression of a disease (SARS-CoV-2) along with the timing and sequence of the various pathologies that the disease causes. While at first glance, this may appear to beyond the scope of toxicology, it is not. Toxicology is capable to address disease-induced pathologies because it can use the same skills and tools that it uses for pathologies that xenobiotics cause. Assessing the pathology caused by a disease concurrently with the pathology caused by the drug used to treat the disease, puts toxicology in a position to make a greater contribution to drug development. Repurposing toxicology, just as drugs were repurposed for the COVID-19 pandemic, will avoid missing or misusing a useful therapeutic agent just because the disease-initiated pathology was ignored or unappreciated. äCOVID-19, hydroxychloroquine and the importance of disease progression(epmc).pdf DeepDyve Pubget Overpricing